Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-16-051139

Options or other derivatives

  • EVP & Chief Commercial Officer acquired 9,520 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vounatsos Michel · EVP & Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-05-02 Grant or award : show line 1 in the form Restricted Stock Unit +9,520 $0.00 2019-05-02 9,520 9,520 D
Loading xslF345X03/form4.xml…